Tag: translation

Pluxee delivers solid organic growth performance in Q3 Fiscal 2025, in line with full-year objectives

Q3 Fiscal 2025 Revenues

Jacobio’s IND for Phase I/II Clinical Trial of BET Inhibitor JAB-8263 in Autoimmune Diseases has been Accepted

BEIJING, SHANGHAI and BOSTON, July 2, 2025 /PRNewswire/ -- Jacobio Pharma (1167.HK) announced that it has submitted the Phase I/II Investigational New Drug (IND)...

ZENVIA Reports Q1 2025 Results

CPaaS revenues kept fueling top line in the quarter Transition to Zenvia Customer Cloud moving on as expected Strict expense control with G&A-to-revenues improving 6.7p.p....

OXLUMO® (lumasiran injection) Now Reimbursed in Canada For the Treatment of Primary Hyperoxaluria Type 1 (PH1) in Pediatric and Adult Patients

OXLUMO has been shown to significantly reduce urinary oxalate, which drives the progression of PH1 Disease1 MISSISSAUGA, ON, July 2, 2025 /CNW/ - Alnylam Canada ULC...

Elementium awarded $100,000 SuperBoost Grant to scale production of next-generation battery electrolytes

Elementium, an energy storage startup developing novel battery electrolytes, receives a $100,000 SuperBoost grant from the NSF Energy Storage Engine.

EZGO ANNOUNCES FINANCIAL RESULTS FOR THE SIX MONTHS ENDED MARCH 31, 2025

CHANGZHOU, China, July 1, 2025 /PRNewswire/ -- EZGO Technologies Ltd. (Nasdaq: EZGO) ("EZGO" or "we", "our", or the "Company"), a leading short-distance transportation solutions...

VIDIZMO Earns Microsoft Solutions Partner Designations for All Three Areas of Azure, Solidifying its Expertise in Delivering AI Solutions

VIDIZMO secures Microsoft Solutions Partner status for Data & AI, Infrastructure, and Digital & App Innovation, underscoring its commitment to delivering AI-powered digital content...

YAS Partners with JOIE to Launch Hong Kong’s First Taxi Fleet with Driving Behavior-Based Insurance

Data-Driven Innovation to Enhance Road Safety and Fleet Transparency HONG KONG, June 27, 2025 /PRNewswire/ -- Insurtech company YAS today announced a strategic partnership with JOIE, a next-generation...

Everest Medicines to Host Virtual Nephrology-Focused KOL Event on June 30, 2025

SHANGHAI, June 26, 2025 (GLOBE NEWSWIRE) -- Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that it will host a virtual nephrology-focused key opinion leader (KOL) event on Monday, June 30, 2025 at 8:00 AM ET. For English speakers, please click here to register. For individuals preferring instant Chinese translation, please click here.

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Phone

This field is for validation purposes and should be left unchanged.

HomeTagsTranslation

Form 8.5 (EPT/RI) – Dowlais Group plc

EQT to acquire Europa Biosite, a distributor of life science products

Groundbreaking pan-European study by Alpharmaxim and Aston University harnesses behavioural science to uncover factors influencing prescribing practice in Parkinson’s Disease and identifies clear opportunities...

Tag: translation

Pluxee delivers solid organic growth performance in Q3 Fiscal 2025, in line with full-year objectives

Jacobio’s IND for Phase I/II Clinical Trial of BET Inhibitor JAB-8263 in Autoimmune Diseases has been Accepted

ZENVIA Reports Q1 2025 Results

OXLUMO® (lumasiran injection) Now Reimbursed in Canada For the Treatment of Primary Hyperoxaluria Type 1 (PH1) in Pediatric and Adult Patients

Elementium awarded $100,000 SuperBoost Grant to scale production of next-generation battery electrolytes

EZGO ANNOUNCES FINANCIAL RESULTS FOR THE SIX MONTHS ENDED MARCH 31, 2025

VIDIZMO Earns Microsoft Solutions Partner Designations for All Three Areas of Azure, Solidifying its Expertise in Delivering AI Solutions

YAS Partners with JOIE to Launch Hong Kong’s First Taxi Fleet with Driving Behavior-Based Insurance

Everest Medicines to Host Virtual Nephrology-Focused KOL Event on June 30, 2025

McCORMICK REPORTS STRONG SECOND QUARTER PERFORMANCE AND REAFFIRMS 2025 OUTLOOK

ALIMENTATION COUCHE-TARD ANNOUNCES ITS RESULTS FOR ITS FOURTH QUARTER AND FISCAL YEAR 2025

ALIMENTATION COUCHE-TARD ANNOUNCES ITS RESULTS FOR ITS FOURTH QUARTER AND FISCAL YEAR 2025

Lotus Technology Reports Unaudited First Quarter 2025 Financial Results

Anthropic Wins a Battle, But the War Ain’t Over

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us